Company: CERO
Filing Date: 2025-05-07
Form Type: DEF 14A
Source: 0001213900-25-040263
Chunk: 6

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-07
Form: DEF 14A
Chunk 6
---
 that may be instituted against us; •our ability to realize the anticipated benefits of any strategic transactions; •our ability to attract and retain the continued service of our key personnel and to identify, hire, and then retain additional qualified personnel and our ability to attract additional collaborators with development, regulatory and commercialization expertise; •our ability to maintain proper and effective internal controls; •the ability to obtain or maintain the listing of our common stock, and our public warrants on the Nasdaq Stock Market (“Nasdaq”); •the impact of macroeconomic conditions and geopolitical turmoil on our business and operations; •our expectations regarding the period during which we will qualify as an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and as a smaller reporting company under the federal securities laws; and •our anticipated use of our existing cash, cash equivalents and marketable securities. We have based these forward -lookingstatements largely on the Company’s current expectations and projections about the Company’s business, the industry in which we operate and financial trends that we believe may affect the Company’s business, financial condition, results of operations and prospects, and these forward -lookingstatements are not guarantees of future performance or development. These forward -lookingstatements speak only as of the date of this proxy statement and are subject to a number of risks, uncertainties and assumptions described in “ Risk Factors” in the Company’s Annual Report on Form 10 -Kfor the fiscal year ended December 31, 2024 and elsewhere in this proxy statement. Because forward -lookingstatements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward -lookingstatements as predictions of future events. The events and circumstances reflected in the Company’s forward -lookingstatements may not be achieved or occur and actual results could differ materially from those projected in the forward -lookingstatements. Except as required by applicable law, we do not plan to publicly update or revise any forward -lookingstatements contained herein until after we distribute this proxy statement, whether as a result of any new information, future events or otherwise. In addition, statements that “we believe” and similar statements reflect the Company’s beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this proxy statement, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and the Company’s statements should not be read to indicate that the Company has